UnknownNot Applicable

Intra-uterine Fetal Brain Activity Monitoring.

20 participantsStarted 2022-12-31

Plain-language summary

Fetal cardiac monitoring is used during labor. Fetal decelerations may imply fetal hypoxia and distress. Brain activity monitoring is not used to evaluate fetal distress during labor. In this study the investigators intend to use an EEG based algorithm to evaluate and monitor fetal brain activity during the 2nd stage of labor.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Vaginal delivery course. * Patient with epidural anesthesia. * Continous fetal heart-rate monitoring. * Singleton pregnancy. * Term pregnancy. Exclusion Criteria: * Suspected Chorioamnionitis. * No epidural anesthesia. * Multiple pregnancy. * Fetal abnormality with emphasis on brain abnormalities. * Preeclampsia. * Patients refusing continous fetal heart-rate monitoring. * Patients in need of a scalp electrode for fetal monitoring. * Patients that received Dolestine during labor. * Patients with Hepatitis B, Hepatitis C and HIV carriers or any other vertically transmitted pathogenic agent.

What they're measuring

Newborn blood gases

Timeframe: From the beginning of the 2nd stage of labor up to 5 minutes postpartum.

Trial details

NCT IDNCT03930277

SponsorRambam Health Care Campus

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

Contact for this trial

Roy Lauterbach, MD

972-52-9432416 r_lauterbach@rambam.health.gov.il

View on ClinicalTrials.gov More Fetal Hypoxia trials